Philippa Marrack
Concepts (887)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 225 | 2021 | 1737 | 8.850 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 62 | 2019 | 309 | 5.150 |
Why?
| Receptors, Antigen, T-Cell | 112 | 2021 | 615 | 5.040 |
Why?
| Lymphocyte Activation | 74 | 2020 | 1037 | 4.610 |
Why?
| B-Lymphocytes | 65 | 2018 | 766 | 4.270 |
Why?
| Histocompatibility Antigens Class II | 73 | 2021 | 352 | 3.880 |
Why?
| Thymus Gland | 59 | 2019 | 296 | 3.820 |
Why?
| CD4-Positive T-Lymphocytes | 40 | 2021 | 959 | 3.750 |
Why?
| Autoimmunity | 17 | 2023 | 813 | 3.670 |
Why?
| Adjuvants, Immunologic | 14 | 2017 | 206 | 3.630 |
Why?
| Major Histocompatibility Complex | 57 | 2021 | 217 | 3.560 |
Why?
| CD8-Positive T-Lymphocytes | 22 | 2021 | 687 | 3.120 |
Why?
| Immunologic Memory | 27 | 2020 | 313 | 3.030 |
Why?
| Histocompatibility Antigens | 18 | 2019 | 98 | 2.780 |
Why?
| Mice | 314 | 2021 | 14869 | 2.730 |
Why?
| Animals | 358 | 2021 | 31706 | 2.470 |
Why?
| T-Lymphocyte Subsets | 22 | 2018 | 383 | 2.130 |
Why?
| Peptides | 42 | 2021 | 848 | 2.070 |
Why?
| B-Lymphocyte Subsets | 8 | 2020 | 68 | 2.060 |
Why?
| Antigens | 38 | 2020 | 318 | 1.950 |
Why?
| Alum Compounds | 7 | 2017 | 22 | 1.940 |
Why?
| Proto-Oncogene Proteins | 13 | 2009 | 608 | 1.900 |
Why?
| Apoptosis | 17 | 2018 | 2363 | 1.770 |
Why?
| Mice, Inbred C57BL | 103 | 2020 | 4694 | 1.750 |
Why?
| Immune Tolerance | 30 | 2021 | 323 | 1.700 |
Why?
| Toll-Like Receptor 7 | 5 | 2016 | 35 | 1.570 |
Why?
| Dendritic Cells | 11 | 2017 | 435 | 1.560 |
Why?
| T-Box Domain Proteins | 7 | 2020 | 92 | 1.560 |
Why?
| Hybridomas | 73 | 2019 | 230 | 1.510 |
Why?
| Apoptosis Regulatory Proteins | 11 | 2011 | 171 | 1.490 |
Why?
| Enterotoxins | 26 | 2009 | 88 | 1.460 |
Why?
| Aging | 11 | 2018 | 1618 | 1.420 |
Why?
| Membrane Proteins | 12 | 2020 | 1019 | 1.300 |
Why?
| Mice, Transgenic | 43 | 2018 | 1949 | 1.250 |
Why?
| Superantigens | 20 | 2019 | 69 | 1.250 |
Why?
| Antigen-Presenting Cells | 21 | 2015 | 150 | 1.240 |
Why?
| Autoantigens | 17 | 2021 | 396 | 1.210 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 213 | 1.210 |
Why?
| Autoimmune Diseases | 10 | 2021 | 382 | 1.200 |
Why?
| H-2 Antigens | 38 | 2011 | 110 | 1.200 |
Why?
| CD11c Antigen | 5 | 2020 | 38 | 1.180 |
Why?
| Antigen Presentation | 15 | 2017 | 188 | 1.070 |
Why?
| Antigens, Surface | 24 | 2011 | 146 | 1.060 |
Why?
| Peptide Fragments | 18 | 2021 | 666 | 1.050 |
Why?
| Immunity, Cellular | 15 | 2010 | 248 | 1.050 |
Why?
| Amino Acid Sequence | 65 | 2019 | 1982 | 1.040 |
Why?
| Spleen | 27 | 2016 | 487 | 1.040 |
Why?
| Vaccines | 4 | 2017 | 375 | 1.030 |
Why?
| Protein Binding | 31 | 2021 | 1890 | 1.010 |
Why?
| Herpesviridae Infections | 3 | 2017 | 138 | 1.000 |
Why?
| Immune System | 7 | 2013 | 172 | 1.000 |
Why?
| Berylliosis | 5 | 2020 | 177 | 0.990 |
Why?
| Autoantibodies | 7 | 2023 | 1346 | 0.970 |
Why?
| Signal Transduction | 21 | 2018 | 4513 | 0.950 |
Why?
| Interleukin-2 | 38 | 2015 | 413 | 0.940 |
Why?
| Mammary Tumor Virus, Mouse | 12 | 1995 | 42 | 0.940 |
Why?
| Interleukin-12 | 2 | 2016 | 110 | 0.930 |
Why?
| Epitopes | 46 | 2021 | 435 | 0.930 |
Why?
| Antigens, Viral | 10 | 2001 | 176 | 0.920 |
Why?
| Clone Cells | 18 | 2008 | 247 | 0.910 |
Why?
| Interferon-gamma | 13 | 2016 | 719 | 0.900 |
Why?
| Gene Expression Regulation | 21 | 2015 | 2320 | 0.900 |
Why?
| Molecular Sequence Data | 60 | 2015 | 2785 | 0.880 |
Why?
| Immunoglobulin G | 8 | 2017 | 770 | 0.800 |
Why?
| Cytokines | 16 | 2020 | 1841 | 0.780 |
Why?
| Sarcoidosis, Pulmonary | 2 | 2020 | 58 | 0.760 |
Why?
| Cell Differentiation | 31 | 2018 | 1701 | 0.750 |
Why?
| Carrier Proteins | 11 | 2009 | 695 | 0.700 |
Why?
| Antibody Formation | 19 | 2017 | 266 | 0.700 |
Why?
| Flow Cytometry | 26 | 2015 | 1083 | 0.690 |
Why?
| Mice, Inbred BALB C | 48 | 2021 | 1144 | 0.680 |
Why?
| Cell Survival | 17 | 2009 | 1021 | 0.680 |
Why?
| Aluminum | 2 | 2010 | 34 | 0.680 |
Why?
| Genes, MHC Class II | 19 | 2014 | 69 | 0.680 |
Why?
| Lymphocytes | 5 | 2018 | 330 | 0.670 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 86 | 0.670 |
Why?
| Alleles | 12 | 2017 | 789 | 0.670 |
Why?
| Mice, Knockout | 20 | 2017 | 2570 | 0.660 |
Why?
| Obsessive-Compulsive Disorder | 1 | 2019 | 32 | 0.660 |
Why?
| Cell Death | 15 | 2019 | 323 | 0.650 |
Why?
| Ovalbumin | 22 | 2011 | 161 | 0.640 |
Why?
| Mice, Inbred Strains | 36 | 2000 | 396 | 0.630 |
Why?
| bcl-2-Associated X Protein | 5 | 2006 | 45 | 0.630 |
Why?
| Antibodies, Monoclonal | 52 | 2016 | 1262 | 0.620 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 590 | 0.620 |
Why?
| Natural Killer T-Cells | 6 | 2018 | 63 | 0.610 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 797 | 0.610 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2017 | 219 | 0.610 |
Why?
| CD8 Antigens | 10 | 2013 | 69 | 0.600 |
Why?
| Cells, Cultured | 27 | 2019 | 3886 | 0.600 |
Why?
| Thymocytes | 3 | 2018 | 28 | 0.600 |
Why?
| Disease Susceptibility | 1 | 2019 | 316 | 0.580 |
Why?
| Humans | 122 | 2023 | 114686 | 0.580 |
Why?
| Amino Acids | 5 | 2022 | 448 | 0.580 |
Why?
| Interleukin-4 | 6 | 2008 | 206 | 0.580 |
Why?
| Interleukin-15 | 6 | 2013 | 74 | 0.580 |
Why?
| Interleukin-7 | 4 | 2004 | 45 | 0.570 |
Why?
| Herpesviridae | 1 | 2017 | 21 | 0.570 |
Why?
| Cat Diseases | 1 | 2017 | 13 | 0.570 |
Why?
| Cell Line | 41 | 2021 | 2637 | 0.560 |
Why?
| Epitopes, T-Lymphocyte | 6 | 2021 | 170 | 0.560 |
Why?
| Cell Proliferation | 12 | 2020 | 2187 | 0.550 |
Why?
| Membrane Glycoproteins | 6 | 2013 | 430 | 0.550 |
Why?
| Homeostasis | 5 | 2007 | 573 | 0.540 |
Why?
| Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.540 |
Why?
| Friend murine leukemia virus | 1 | 2016 | 30 | 0.540 |
Why?
| Deoxyribonucleases | 1 | 2016 | 21 | 0.540 |
Why?
| Ikaros Transcription Factor | 2 | 2013 | 17 | 0.530 |
Why?
| Models, Molecular | 25 | 2018 | 1369 | 0.520 |
Why?
| Antigens, Neoplasm | 4 | 2021 | 222 | 0.520 |
Why?
| Complementarity Determining Regions | 6 | 2011 | 43 | 0.520 |
Why?
| Reactive Oxygen Species | 3 | 2003 | 531 | 0.500 |
Why?
| Influenza A virus | 2 | 2013 | 90 | 0.500 |
Why?
| Staphylococcus aureus | 12 | 1999 | 389 | 0.490 |
Why?
| Antigens, Bacterial | 8 | 2013 | 112 | 0.490 |
Why?
| Evolution, Molecular | 4 | 2019 | 430 | 0.480 |
Why?
| Immunity, Innate | 6 | 2019 | 720 | 0.480 |
Why?
| Histocompatibility Antigens Class I | 10 | 2013 | 172 | 0.480 |
Why?
| Cell Division | 10 | 2008 | 758 | 0.470 |
Why?
| Histone Demethylases | 3 | 2020 | 28 | 0.470 |
Why?
| Viral Proteins | 2 | 2009 | 281 | 0.440 |
Why?
| Protein Conformation | 19 | 2018 | 805 | 0.440 |
Why?
| Models, Immunological | 8 | 2017 | 92 | 0.430 |
Why?
| Clonal Deletion | 4 | 2004 | 16 | 0.430 |
Why?
| Nucleoproteins | 1 | 2013 | 27 | 0.430 |
Why?
| Gammaherpesvirinae | 1 | 2013 | 38 | 0.430 |
Why?
| T-Lymphocytes, Cytotoxic | 5 | 2012 | 154 | 0.420 |
Why?
| Mutation | 22 | 2022 | 3346 | 0.420 |
Why?
| Th2 Cells | 3 | 2010 | 154 | 0.420 |
Why?
| Hypersensitivity | 2 | 2014 | 252 | 0.420 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 66 | 0.420 |
Why?
| DNA | 10 | 2016 | 1352 | 0.420 |
Why?
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 92 | 0.400 |
Why?
| Lymphocyte Cooperation | 22 | 2006 | 49 | 0.400 |
Why?
| Female | 65 | 2021 | 59507 | 0.400 |
Why?
| Base Sequence | 33 | 2015 | 2114 | 0.400 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 33 | 0.400 |
Why?
| Antibodies | 7 | 2009 | 371 | 0.380 |
Why?
| bcl-X Protein | 4 | 2006 | 38 | 0.380 |
Why?
| Staphylococcus | 5 | 1994 | 69 | 0.380 |
Why?
| Binding Sites | 19 | 2021 | 1168 | 0.380 |
Why?
| Receptors, Cell Surface | 4 | 2020 | 355 | 0.380 |
Why?
| Clonal Anergy | 3 | 2006 | 53 | 0.380 |
Why?
| Receptors, Chemokine | 2 | 2008 | 44 | 0.370 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 11 | 0.370 |
Why?
| Lipid A | 1 | 2011 | 28 | 0.370 |
Why?
| Chromosomes, Human, X | 2 | 2015 | 60 | 0.370 |
Why?
| Inflammation | 5 | 2020 | 2480 | 0.370 |
Why?
| Th1 Cells | 2 | 2010 | 123 | 0.370 |
Why?
| Vaccines, Subunit | 1 | 2011 | 41 | 0.360 |
Why?
| Mast Cells | 2 | 2009 | 116 | 0.360 |
Why?
| Germ Cells | 2 | 2016 | 57 | 0.350 |
Why?
| Cell Communication | 9 | 2013 | 280 | 0.340 |
Why?
| Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.340 |
Why?
| Genes | 16 | 1990 | 223 | 0.340 |
Why?
| Gonadal Steroid Hormones | 2 | 2014 | 124 | 0.340 |
Why?
| Nobel Prize | 1 | 2009 | 4 | 0.340 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 13 | 0.340 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 17 | 1991 | 84 | 0.330 |
Why?
| Genetics, Medical | 1 | 2009 | 24 | 0.330 |
Why?
| Protein Processing, Post-Translational | 7 | 2018 | 399 | 0.330 |
Why?
| Glycoproteins | 3 | 2011 | 304 | 0.330 |
Why?
| Macrophages, Peritoneal | 1 | 2009 | 93 | 0.320 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2011 | 41 | 0.320 |
Why?
| HLA-DR Antigens | 8 | 2008 | 219 | 0.310 |
Why?
| Receptors, Immunologic | 3 | 2020 | 201 | 0.310 |
Why?
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 740 | 0.310 |
Why?
| Cell Movement | 7 | 2017 | 869 | 0.310 |
Why?
| Cytotoxicity, Immunologic | 7 | 2009 | 195 | 0.310 |
Why?
| Vaccination | 4 | 2010 | 1204 | 0.310 |
Why?
| Herpesvirus 4, Human | 1 | 2009 | 125 | 0.310 |
Why?
| Transcription Factors | 5 | 2012 | 1528 | 0.300 |
Why?
| Binding, Competitive | 8 | 2003 | 193 | 0.300 |
Why?
| Allergy and Immunology | 2 | 2006 | 51 | 0.290 |
Why?
| CD3 Complex | 8 | 2009 | 92 | 0.290 |
Why?
| Genetic Predisposition to Disease | 4 | 2010 | 2086 | 0.280 |
Why?
| Bone Marrow Cells | 5 | 2016 | 267 | 0.280 |
Why?
| Receptors, Interleukin-2 | 4 | 2003 | 64 | 0.280 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 59 | 0.280 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2021 | 3252 | 0.280 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 25 | 0.280 |
Why?
| Gene Expression Profiling | 6 | 2018 | 1518 | 0.280 |
Why?
| Histones | 3 | 2018 | 535 | 0.270 |
Why?
| HLA-DP beta-Chains | 4 | 2014 | 76 | 0.270 |
Why?
| Inflammation Mediators | 1 | 2009 | 477 | 0.270 |
Why?
| T-Lymphocytes, Helper-Inducer | 10 | 1989 | 127 | 0.260 |
Why?
| Transfection | 16 | 2008 | 866 | 0.260 |
Why?
| Lipopolysaccharides | 10 | 2005 | 823 | 0.260 |
Why?
| History, 20th Century | 6 | 2016 | 264 | 0.260 |
Why?
| Bacterial Toxins | 6 | 1997 | 103 | 0.250 |
Why?
| Lymph Nodes | 13 | 2015 | 419 | 0.250 |
Why?
| Insulin | 4 | 2019 | 2079 | 0.250 |
Why?
| Mitochondria | 4 | 2008 | 747 | 0.250 |
Why?
| Antigens, CD1d | 5 | 2013 | 63 | 0.250 |
Why?
| RNA, Messenger | 10 | 2022 | 2553 | 0.240 |
Why?
| Cell Membrane | 6 | 2004 | 680 | 0.240 |
Why?
| Repressor Proteins | 2 | 2015 | 366 | 0.240 |
Why?
| Protein Folding | 1 | 2006 | 239 | 0.240 |
Why?
| Gene Expression | 10 | 2017 | 1421 | 0.240 |
Why?
| Immunoglobulin Variable Region | 11 | 2012 | 72 | 0.230 |
Why?
| Baculoviridae | 7 | 2015 | 44 | 0.230 |
Why?
| Beryllium | 3 | 2014 | 146 | 0.230 |
Why?
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.230 |
Why?
| Interleukin-6 | 3 | 2011 | 676 | 0.230 |
Why?
| Neoplasms, Experimental | 3 | 2021 | 151 | 0.230 |
Why?
| Lymphokines | 13 | 1984 | 111 | 0.220 |
Why?
| Cell Separation | 12 | 2008 | 291 | 0.220 |
Why?
| Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 13 | 0.220 |
Why?
| Crystallography, X-Ray | 9 | 2018 | 402 | 0.220 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2020 | 22 | 0.220 |
Why?
| Lysosomes | 2 | 2021 | 123 | 0.210 |
Why?
| Genes, bcl-2 | 1 | 2002 | 20 | 0.210 |
Why?
| Oligopeptides | 2 | 2001 | 236 | 0.210 |
Why?
| Chromogranin A | 2 | 2015 | 39 | 0.210 |
Why?
| beta 2-Microglobulin | 4 | 2010 | 45 | 0.210 |
Why?
| Ubiquitin-Protein Ligases | 3 | 2008 | 139 | 0.210 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 663 | 0.210 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2017 | 339 | 0.200 |
Why?
| Cloning, Molecular | 13 | 2017 | 522 | 0.200 |
Why?
| Radiation Chimera | 4 | 2001 | 30 | 0.200 |
Why?
| Polymorphism, Genetic | 6 | 2012 | 610 | 0.200 |
Why?
| NF-kappa B | 2 | 2017 | 641 | 0.200 |
Why?
| Transcription, Genetic | 7 | 2020 | 1313 | 0.200 |
Why?
| Cell Culture Techniques | 2 | 2001 | 343 | 0.200 |
Why?
| Ligands | 9 | 2022 | 562 | 0.200 |
Why?
| Lung Diseases | 2 | 2010 | 701 | 0.200 |
Why?
| Egg Proteins | 1 | 2001 | 19 | 0.200 |
Why?
| Concanavalin A | 17 | 1990 | 74 | 0.200 |
Why?
| Cross Reactions | 7 | 2012 | 117 | 0.200 |
Why?
| Moloney murine leukemia virus | 1 | 2001 | 11 | 0.190 |
Why?
| Mice, Mutant Strains | 7 | 2008 | 271 | 0.190 |
Why?
| Cytochrome c Group | 4 | 1997 | 36 | 0.190 |
Why?
| Open Reading Frames | 3 | 1992 | 117 | 0.190 |
Why?
| Interferon-alpha | 4 | 2014 | 186 | 0.190 |
Why?
| B7-1 Antigen | 3 | 2004 | 53 | 0.190 |
Why?
| Transduction, Genetic | 1 | 2001 | 113 | 0.190 |
Why?
| Receptors, Fc | 2 | 2020 | 45 | 0.190 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 104 | 0.190 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 367 | 0.180 |
Why?
| Cathepsins | 1 | 2021 | 22 | 0.180 |
Why?
| Immunoglobulin Idiotypes | 7 | 1986 | 19 | 0.180 |
Why?
| Macromolecular Substances | 16 | 2003 | 200 | 0.180 |
Why?
| HLA-C Antigens | 1 | 2021 | 33 | 0.180 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2006 | 1140 | 0.180 |
Why?
| Chimera | 8 | 2009 | 59 | 0.180 |
Why?
| Hematopoietic Stem Cells | 4 | 2014 | 343 | 0.180 |
Why?
| Genetic Vectors | 2 | 2001 | 289 | 0.180 |
Why?
| Immunity | 3 | 2007 | 121 | 0.180 |
Why?
| Sex Characteristics | 3 | 2015 | 640 | 0.180 |
Why?
| RNA Polymerase II | 2 | 2020 | 284 | 0.180 |
Why?
| Disease Models, Animal | 6 | 2014 | 3535 | 0.180 |
Why?
| Immunity, Humoral | 2 | 2022 | 112 | 0.180 |
Why?
| Self Tolerance | 3 | 2017 | 28 | 0.180 |
Why?
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 9 | 0.180 |
Why?
| Kidney | 2 | 2017 | 1188 | 0.180 |
Why?
| HLA-DQ Antigens | 2 | 2019 | 174 | 0.180 |
Why?
| Protein Structure, Tertiary | 7 | 2021 | 796 | 0.180 |
Why?
| Interferon-beta | 3 | 2007 | 79 | 0.170 |
Why?
| Mice, Inbred NOD | 7 | 2019 | 555 | 0.170 |
Why?
| Male | 30 | 2020 | 55596 | 0.170 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 228 | 0.170 |
Why?
| Transcription Factor AP-1 | 1 | 2000 | 80 | 0.170 |
Why?
| Lymphocytic choriomeningitis virus | 2 | 2011 | 20 | 0.170 |
Why?
| Genome | 2 | 2000 | 271 | 0.170 |
Why?
| Receptors, Complement 3d | 1 | 2020 | 130 | 0.170 |
Why?
| Neoplasms | 3 | 2021 | 2097 | 0.170 |
Why?
| Case-Control Studies | 2 | 2020 | 3003 | 0.170 |
Why?
| Methyltransferases | 1 | 2020 | 61 | 0.160 |
Why?
| Peptide Library | 4 | 2013 | 81 | 0.160 |
Why?
| Vaccinia | 1 | 1999 | 18 | 0.160 |
Why?
| Macrophages | 17 | 1988 | 1263 | 0.160 |
Why?
| CD28 Antigens | 2 | 2008 | 47 | 0.160 |
Why?
| fas Receptor | 4 | 2002 | 91 | 0.160 |
Why?
| Immunotherapy | 3 | 2021 | 474 | 0.160 |
Why?
| Mass Spectrometry | 3 | 2020 | 633 | 0.160 |
Why?
| Adaptive Immunity | 2 | 2017 | 155 | 0.160 |
Why?
| Caspase 1 | 2 | 2009 | 140 | 0.160 |
Why?
| Lymphocyte Count | 4 | 2010 | 133 | 0.160 |
Why?
| Trans-Activators | 2 | 2000 | 367 | 0.160 |
Why?
| Germinal Center | 2 | 2017 | 48 | 0.150 |
Why?
| Antigens, CD | 4 | 2000 | 442 | 0.150 |
Why?
| Nickel | 2 | 2012 | 50 | 0.150 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 144 | 0.150 |
Why?
| Dose-Response Relationship, Immunologic | 11 | 2000 | 75 | 0.150 |
Why?
| Adoptive Transfer | 6 | 2015 | 195 | 0.150 |
Why?
| Crosses, Genetic | 6 | 2006 | 139 | 0.150 |
Why?
| Interferon Type I | 1 | 1999 | 128 | 0.150 |
Why?
| Time Factors | 10 | 2013 | 6115 | 0.150 |
Why?
| Complement C3b Inactivator Proteins | 1 | 2017 | 9 | 0.150 |
Why?
| Minor Histocompatibility Antigens | 2 | 2015 | 41 | 0.150 |
Why?
| Receptors, Interferon | 2 | 2013 | 47 | 0.150 |
Why?
| CD4 Antigens | 9 | 1998 | 123 | 0.140 |
Why?
| Retinal Pigment Epithelium | 1 | 2017 | 58 | 0.140 |
Why?
| Mice, Inbred DBA | 18 | 2001 | 174 | 0.140 |
Why?
| Complement Factor H | 1 | 2017 | 60 | 0.140 |
Why?
| Phenotype | 9 | 2008 | 2796 | 0.140 |
Why?
| Receptors, IgE | 1 | 1997 | 40 | 0.140 |
Why?
| Substrate Specificity | 1 | 2017 | 352 | 0.140 |
Why?
| Cats | 1 | 2017 | 193 | 0.140 |
Why?
| Blotting, Western | 3 | 2020 | 1147 | 0.140 |
Why?
| Mice, Inbred C3H | 8 | 1993 | 239 | 0.140 |
Why?
| Complement Pathway, Alternative | 1 | 2017 | 114 | 0.140 |
Why?
| Drug Contamination | 1 | 2016 | 52 | 0.130 |
Why?
| Lupus Nephritis | 4 | 2012 | 52 | 0.130 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 90 | 0.130 |
Why?
| Graft Rejection | 3 | 2015 | 513 | 0.130 |
Why?
| Immunoconjugates | 1 | 1997 | 87 | 0.130 |
Why?
| HLA Antigens | 3 | 2013 | 225 | 0.130 |
Why?
| Hematopoiesis | 1 | 1997 | 171 | 0.130 |
Why?
| Imidazoles | 1 | 2016 | 208 | 0.130 |
Why?
| Serum Albumin, Bovine | 5 | 2011 | 61 | 0.130 |
Why?
| Chemokine CCL19 | 1 | 2015 | 6 | 0.130 |
Why?
| Chemokine CCL21 | 1 | 2015 | 13 | 0.130 |
Why?
| Down-Regulation | 3 | 2003 | 594 | 0.130 |
Why?
| Receptors, CCR7 | 1 | 2015 | 24 | 0.120 |
Why?
| Antiviral Agents | 1 | 2021 | 645 | 0.120 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 82 | 0.120 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 39 | 0.120 |
Why?
| Immunization | 8 | 2013 | 397 | 0.120 |
Why?
| Nicotine | 1 | 2017 | 265 | 0.120 |
Why?
| Skin Transplantation | 1 | 2015 | 57 | 0.120 |
Why?
| Sequence Homology, Nucleic Acid | 7 | 1992 | 152 | 0.120 |
Why?
| Thymoma | 4 | 2012 | 30 | 0.120 |
Why?
| Amino Acid Motifs | 5 | 2019 | 197 | 0.120 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 268 | 0.120 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1988 | 72 | 0.120 |
Why?
| Macrophages, Alveolar | 1 | 2017 | 348 | 0.120 |
Why?
| Epithelium | 6 | 1997 | 295 | 0.120 |
Why?
| Green Fluorescent Proteins | 3 | 2013 | 371 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 923 | 0.110 |
Why?
| Granuloma | 1 | 2014 | 83 | 0.110 |
Why?
| Antibodies, Viral | 1 | 2017 | 520 | 0.110 |
Why?
| Hybridization, Genetic | 2 | 2014 | 78 | 0.110 |
Why?
| Molecular Weight | 11 | 2006 | 331 | 0.110 |
Why?
| Organ Culture Techniques | 6 | 1993 | 140 | 0.110 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 372 | 0.110 |
Why?
| Fluorescent Antibody Technique | 4 | 2004 | 397 | 0.110 |
Why?
| Receptors, Interleukin-7 | 2 | 2006 | 25 | 0.110 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 351 | 0.110 |
Why?
| Conserved Sequence | 3 | 2009 | 218 | 0.110 |
Why?
| Heparin-binding EGF-like Growth Factor | 1 | 2013 | 11 | 0.110 |
Why?
| Escherichia coli | 4 | 2013 | 720 | 0.110 |
Why?
| Age Factors | 4 | 2017 | 2894 | 0.110 |
Why?
| Kinetics | 13 | 2021 | 1551 | 0.110 |
Why?
| Lymphocytes, Null | 1 | 2012 | 2 | 0.110 |
Why?
| HLA-DR4 Antigen | 2 | 2005 | 76 | 0.110 |
Why?
| Killer Cells, Natural | 2 | 2007 | 380 | 0.110 |
Why?
| Diphtheria Toxin | 1 | 2013 | 51 | 0.100 |
Why?
| Minor Histocompatibility Loci | 2 | 1990 | 4 | 0.100 |
Why?
| Mice, Nude | 3 | 2013 | 630 | 0.100 |
Why?
| Cell Lineage | 2 | 2013 | 309 | 0.100 |
Why?
| Genes, Immunoglobulin | 3 | 1988 | 26 | 0.100 |
Why?
| Hemocyanins | 8 | 1983 | 55 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 313 | 0.100 |
Why?
| DNA Primers | 1 | 2013 | 510 | 0.100 |
Why?
| Immunophenotyping | 3 | 2004 | 274 | 0.100 |
Why?
| Rhadinovirus | 1 | 2012 | 16 | 0.100 |
Why?
| Haplotypes | 4 | 1990 | 448 | 0.100 |
Why?
| Galactosylceramides | 2 | 2012 | 22 | 0.100 |
Why?
| Communicable Diseases | 1 | 1994 | 129 | 0.100 |
Why?
| Tumor Virus Infections | 1 | 2012 | 43 | 0.100 |
Why?
| Burkitt Lymphoma | 1 | 2012 | 52 | 0.100 |
Why?
| Virus Diseases | 2 | 1992 | 195 | 0.100 |
Why?
| Mice, Inbred CBA | 8 | 1991 | 49 | 0.100 |
Why?
| Dermatitis, Allergic Contact | 1 | 2012 | 63 | 0.100 |
Why?
| Ubiquitination | 2 | 2008 | 86 | 0.100 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2007 | 61 | 0.090 |
Why?
| Nucleocapsid Proteins | 1 | 2011 | 24 | 0.090 |
Why?
| Viral Core Proteins | 1 | 2011 | 20 | 0.090 |
Why?
| Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.090 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.090 |
Why?
| Cell Line, Tumor | 4 | 2021 | 2710 | 0.090 |
Why?
| Surface Plasmon Resonance | 3 | 2021 | 81 | 0.090 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 54 | 0.090 |
Why?
| Salts | 1 | 2010 | 36 | 0.090 |
Why?
| Bone Marrow | 2 | 2009 | 243 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 7 | 2011 | 318 | 0.090 |
Why?
| Structure-Activity Relationship | 8 | 2006 | 502 | 0.090 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 801 | 0.090 |
Why?
| Antibody Specificity | 7 | 1997 | 176 | 0.090 |
Why?
| Fibrin | 1 | 2010 | 65 | 0.090 |
Why?
| Recombinant Proteins | 7 | 2005 | 1230 | 0.090 |
Why?
| HLA-DP Antigens | 1 | 2010 | 32 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2008 | 151 | 0.090 |
Why?
| Cattle | 2 | 2011 | 920 | 0.090 |
Why?
| Antibodies, Neutralizing | 2 | 2022 | 222 | 0.090 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 6 | 1999 | 31 | 0.080 |
Why?
| Antigen-Antibody Reactions | 6 | 2021 | 50 | 0.080 |
Why?
| Molecular Docking Simulation | 2 | 2021 | 101 | 0.080 |
Why?
| Fibrinogen | 1 | 2010 | 154 | 0.080 |
Why?
| France | 1 | 2009 | 34 | 0.080 |
Why?
| Thrombin | 1 | 2010 | 139 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2020 | 6347 | 0.080 |
Why?
| Retroviridae | 2 | 2013 | 90 | 0.080 |
Why?
| Injections, Intraperitoneal | 1 | 2009 | 99 | 0.080 |
Why?
| Antioxidants | 2 | 2003 | 530 | 0.080 |
Why?
| Phosphorylation | 4 | 2020 | 1569 | 0.080 |
Why?
| Biomarkers | 1 | 2019 | 3408 | 0.080 |
Why?
| Aluminum Compounds | 1 | 2009 | 6 | 0.080 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2011 | 194 | 0.080 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2009 | 17 | 0.080 |
Why?
| Immunoglobulin Class Switching | 1 | 2009 | 15 | 0.080 |
Why?
| Aged | 3 | 2020 | 19074 | 0.080 |
Why?
| Cell Adhesion Molecules | 1 | 1990 | 168 | 0.080 |
Why?
| Antibody Affinity | 3 | 2005 | 52 | 0.080 |
Why?
| Integrin alpha4 | 1 | 2008 | 6 | 0.080 |
Why?
| History, 21st Century | 1 | 2009 | 159 | 0.080 |
Why?
| Adsorption | 1 | 2009 | 119 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.080 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2008 | 12 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 3 | 2004 | 353 | 0.080 |
Why?
| Protein Domains | 2 | 2020 | 207 | 0.080 |
Why?
| Genes, Switch | 1 | 1988 | 5 | 0.080 |
Why?
| Chondroitin | 1 | 1988 | 5 | 0.080 |
Why?
| Cytoskeletal Proteins | 1 | 2009 | 145 | 0.080 |
Why?
| Antigens, Helminth | 1 | 2008 | 12 | 0.080 |
Why?
| Genes, Regulator | 1 | 1988 | 34 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2013 | 497 | 0.080 |
Why?
| Immunoglobulin Isotypes | 1 | 2008 | 32 | 0.080 |
Why?
| Genetic Linkage | 7 | 1989 | 294 | 0.080 |
Why?
| Biosensing Techniques | 1 | 2009 | 100 | 0.080 |
Why?
| Polymerase Chain Reaction | 6 | 1997 | 993 | 0.080 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 345 | 0.080 |
Why?
| Methylation | 3 | 2018 | 208 | 0.080 |
Why?
| Schistosoma mansoni | 1 | 2008 | 33 | 0.080 |
Why?
| Histocompatibility Antigen H-2D | 3 | 2010 | 21 | 0.070 |
Why?
| Species Specificity | 9 | 2006 | 542 | 0.070 |
Why?
| Chondroitin Sulfates | 1 | 1988 | 33 | 0.070 |
Why?
| Erythrocytes | 15 | 1983 | 591 | 0.070 |
Why?
| Mice, Inbred AKR | 10 | 1989 | 34 | 0.070 |
Why?
| Transplantation Chimera | 3 | 2014 | 51 | 0.070 |
Why?
| Pancreas | 2 | 2021 | 276 | 0.070 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2007 | 23 | 0.070 |
Why?
| Infection Control | 1 | 2009 | 135 | 0.070 |
Why?
| Hybrid Cells | 4 | 1997 | 49 | 0.070 |
Why?
| Fluoresceins | 2 | 2004 | 46 | 0.070 |
Why?
| Moths | 3 | 1997 | 35 | 0.070 |
Why?
| Arthritis, Rheumatoid | 3 | 2005 | 1003 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2003 | 1842 | 0.070 |
Why?
| Immunoglobulin Fab Fragments | 2 | 2006 | 69 | 0.070 |
Why?
| In Vitro Techniques | 8 | 2000 | 1016 | 0.070 |
Why?
| Poly I-C | 1 | 2006 | 51 | 0.070 |
Why?
| Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.070 |
Why?
| Health | 1 | 2007 | 74 | 0.070 |
Why?
| Arginine | 2 | 2018 | 238 | 0.070 |
Why?
| Hyaluronan Receptors | 3 | 2003 | 90 | 0.070 |
Why?
| Chemokines | 1 | 2007 | 216 | 0.070 |
Why?
| B-Cell Activating Factor | 1 | 2006 | 18 | 0.070 |
Why?
| Tissue Distribution | 3 | 1993 | 286 | 0.070 |
Why?
| Chemotaxis, Leukocyte | 2 | 2003 | 130 | 0.070 |
Why?
| Transgenes | 2 | 1997 | 170 | 0.070 |
Why?
| Promoter Regions, Genetic | 4 | 2020 | 1131 | 0.070 |
Why?
| Leukopoiesis | 1 | 2006 | 10 | 0.070 |
Why?
| Peptide Hydrolases | 1 | 2006 | 104 | 0.060 |
Why?
| Spodoptera | 2 | 2021 | 36 | 0.060 |
Why?
| Insulin-Secreting Cells | 1 | 2010 | 317 | 0.060 |
Why?
| Caspases | 2 | 2014 | 245 | 0.060 |
Why?
| Recombinant Fusion Proteins | 4 | 2001 | 616 | 0.060 |
Why?
| Cell Fusion | 4 | 1989 | 50 | 0.060 |
Why?
| Protein Structure, Secondary | 4 | 2012 | 325 | 0.060 |
Why?
| Young Adult | 1 | 2020 | 10469 | 0.060 |
Why?
| Sheep | 11 | 1983 | 764 | 0.060 |
Why?
| HLA-D Antigens | 2 | 1998 | 34 | 0.060 |
Why?
| Enzyme Activation | 3 | 2008 | 785 | 0.060 |
Why?
| Prostaglandins E | 1 | 1985 | 44 | 0.060 |
Why?
| Proteolysis | 2 | 2018 | 142 | 0.060 |
Why?
| Leukemia P388 | 2 | 1984 | 7 | 0.060 |
Why?
| Succinimides | 1 | 2004 | 15 | 0.060 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 73 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.060 |
Why?
| MAP Kinase Kinase Kinases | 2 | 2008 | 68 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1715 | 0.060 |
Why?
| Phosphatidylserines | 1 | 2005 | 87 | 0.060 |
Why?
| Plasmids | 4 | 2001 | 343 | 0.060 |
Why?
| Fibroblasts | 3 | 2017 | 838 | 0.060 |
Why?
| Lung | 4 | 2014 | 3561 | 0.060 |
Why?
| Fetus | 4 | 2014 | 700 | 0.060 |
Why?
| DNA, Complementary | 1 | 2004 | 256 | 0.060 |
Why?
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| Phosphoserine | 1 | 2004 | 33 | 0.060 |
Why?
| Antigens, Differentiation | 2 | 1997 | 79 | 0.060 |
Why?
| Leukemia, Experimental | 1 | 1983 | 27 | 0.060 |
Why?
| Receptors, Leukotriene B4 | 1 | 2003 | 8 | 0.060 |
Why?
| RNA | 3 | 2003 | 809 | 0.060 |
Why?
| Incidence | 1 | 2010 | 2313 | 0.060 |
Why?
| Leukotriene B4 | 1 | 2003 | 48 | 0.060 |
Why?
| Catalase | 1 | 2003 | 118 | 0.060 |
Why?
| Luminescent Proteins | 2 | 2001 | 166 | 0.050 |
Why?
| Chromosome Mapping | 6 | 1989 | 487 | 0.050 |
Why?
| Bone Marrow Transplantation | 3 | 2014 | 239 | 0.050 |
Why?
| Chromosome Deletion | 4 | 1991 | 95 | 0.050 |
Why?
| Protein Biosynthesis | 3 | 1992 | 386 | 0.050 |
Why?
| Selection, Genetic | 2 | 2019 | 242 | 0.050 |
Why?
| Myeloid Cells | 1 | 2004 | 126 | 0.050 |
Why?
| Antibody-Producing Cells | 7 | 1983 | 29 | 0.050 |
Why?
| Fas Ligand Protein | 1 | 2003 | 57 | 0.050 |
Why?
| Fluorescent Dyes | 2 | 2001 | 301 | 0.050 |
Why?
| Solubility | 4 | 1998 | 223 | 0.050 |
Why?
| Binding Sites, Antibody | 5 | 1991 | 36 | 0.050 |
Why?
| Antigens, Ly | 4 | 1988 | 45 | 0.050 |
Why?
| Interleukin-1 | 5 | 1997 | 966 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 124 | 0.050 |
Why?
| Lymphocyte Depletion | 3 | 1992 | 116 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 476 | 0.050 |
Why?
| Chronic Disease | 3 | 2013 | 1578 | 0.050 |
Why?
| Mesencephalon | 1 | 2002 | 57 | 0.050 |
Why?
| Sequence Alignment | 2 | 2008 | 323 | 0.050 |
Why?
| Synovial Fluid | 2 | 2000 | 56 | 0.050 |
Why?
| Tumor Cells, Cultured | 3 | 2000 | 849 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 140 | 0.050 |
Why?
| Calcium | 6 | 2004 | 1108 | 0.050 |
Why?
| Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| Sex Chromosome Aberrations | 1 | 1981 | 51 | 0.050 |
Why?
| Transplantation, Heterologous | 1 | 2002 | 181 | 0.050 |
Why?
| Middle Aged | 2 | 2020 | 26737 | 0.050 |
Why?
| Crystallization | 2 | 2015 | 136 | 0.050 |
Why?
| Interphase | 2 | 2000 | 32 | 0.050 |
Why?
| Vaccinia virus | 1 | 2001 | 27 | 0.050 |
Why?
| Hemolytic Plaque Technique | 10 | 1983 | 29 | 0.050 |
Why?
| Growth Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| Temperature | 1 | 2003 | 565 | 0.050 |
Why?
| Borrelia burgdorferi Group | 1 | 2000 | 8 | 0.050 |
Why?
| Immunosuppressive Agents | 1 | 2005 | 646 | 0.050 |
Why?
| Receptors, Virus | 1 | 2021 | 75 | 0.040 |
Why?
| Adult | 3 | 2020 | 30550 | 0.040 |
Why?
| Up-Regulation | 1 | 2003 | 808 | 0.040 |
Why?
| Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1999 | 187 | 0.040 |
Why?
| Antibody Diversity | 3 | 1989 | 16 | 0.040 |
Why?
| Phorbol Esters | 1 | 2000 | 15 | 0.040 |
Why?
| Lymphocyte Culture Test, Mixed | 3 | 1990 | 41 | 0.040 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 11 | 0.040 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2000 | 59 | 0.040 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 38 | 0.040 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 17 | 0.040 |
Why?
| Haploidy | 1 | 1980 | 21 | 0.040 |
Why?
| Rats | 5 | 2002 | 4958 | 0.040 |
Why?
| Cancer Vaccines | 1 | 2021 | 137 | 0.040 |
Why?
| Receptors, Interleukin-6 | 1 | 2000 | 34 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2021 | 129 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 2012 | 1314 | 0.040 |
Why?
| Jurkat Cells | 1 | 2000 | 128 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 2000 | 64 | 0.040 |
Why?
| Indicators and Reagents | 1 | 2000 | 99 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 98 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2000 | 133 | 0.040 |
Why?
| Lipoproteins | 1 | 2000 | 159 | 0.040 |
Why?
| Lymphocyte Transfusion | 1 | 1999 | 19 | 0.040 |
Why?
| Leukemia L1210 | 1 | 1999 | 7 | 0.040 |
Why?
| Haptens | 3 | 1988 | 21 | 0.040 |
Why?
| Recombination, Genetic | 4 | 1988 | 176 | 0.040 |
Why?
| Lymphopenia | 1 | 1999 | 49 | 0.040 |
Why?
| Chickens | 5 | 1994 | 177 | 0.040 |
Why?
| Free Radical Scavengers | 1 | 1999 | 78 | 0.040 |
Why?
| Peer Review, Research | 1 | 1999 | 34 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 184 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1999 | 106 | 0.040 |
Why?
| Hot Temperature | 2 | 2000 | 302 | 0.040 |
Why?
| Manganese | 1 | 1999 | 55 | 0.040 |
Why?
| Cell Cycle | 2 | 2020 | 542 | 0.040 |
Why?
| Cholic Acids | 1 | 1998 | 17 | 0.040 |
Why?
| Nucleosomes | 1 | 2020 | 123 | 0.040 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 56 | 0.040 |
Why?
| Detergents | 1 | 1998 | 41 | 0.040 |
Why?
| Coculture Techniques | 2 | 2013 | 201 | 0.040 |
Why?
| Metalloporphyrins | 1 | 1999 | 103 | 0.040 |
Why?
| Membrane Potentials | 1 | 1999 | 248 | 0.040 |
Why?
| Behavior, Animal | 1 | 2002 | 458 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 2000 | 173 | 0.040 |
Why?
| Trinitrobenzenes | 5 | 1982 | 13 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 2 | 2005 | 138 | 0.040 |
Why?
| Neutrophils | 1 | 2004 | 1176 | 0.040 |
Why?
| Lymphoma | 5 | 1985 | 177 | 0.040 |
Why?
| Crystallography | 2 | 2007 | 25 | 0.040 |
Why?
| Recovery of Function | 1 | 2002 | 574 | 0.040 |
Why?
| Mice, Inbred A | 6 | 1984 | 45 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| NFATC Transcription Factors | 1 | 2018 | 78 | 0.040 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 97 | 0.040 |
Why?
| Endocytosis | 1 | 1998 | 148 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 1999 | 276 | 0.040 |
Why?
| Autophagosomes | 1 | 2017 | 19 | 0.040 |
Why?
| Nicotinic Antagonists | 1 | 2017 | 20 | 0.040 |
Why?
| Societies, Medical | 1 | 2001 | 664 | 0.040 |
Why?
| STAT6 Transcription Factor | 1 | 1997 | 22 | 0.040 |
Why?
| Mutagenesis | 2 | 2013 | 168 | 0.040 |
Why?
| Dinoprostone | 2 | 1991 | 184 | 0.040 |
Why?
| Phylogeny | 1 | 2021 | 789 | 0.040 |
Why?
| Parkinson Disease | 1 | 2002 | 345 | 0.040 |
Why?
| Abatacept | 1 | 1997 | 40 | 0.040 |
Why?
| Oligonucleotides | 2 | 2004 | 137 | 0.040 |
Why?
| Receptors, Complement | 1 | 2017 | 111 | 0.040 |
Why?
| Columbidae | 2 | 1994 | 31 | 0.040 |
Why?
| Interleukins | 1 | 1999 | 236 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 147 | 0.030 |
Why?
| Immunomodulation | 1 | 2017 | 84 | 0.030 |
Why?
| CTLA-4 Antigen | 1 | 1997 | 76 | 0.030 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 51 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 1997 | 262 | 0.030 |
Why?
| Hemolysis | 1 | 2017 | 146 | 0.030 |
Why?
| Respiratory Hypersensitivity | 1 | 1997 | 60 | 0.030 |
Why?
| Germ-Line Mutation | 2 | 2009 | 130 | 0.030 |
Why?
| Gene Deletion | 2 | 2009 | 356 | 0.030 |
Why?
| Protein Subunits | 1 | 2017 | 201 | 0.030 |
Why?
| Genetic Complementation Test | 2 | 1986 | 62 | 0.030 |
Why?
| Models, Biological | 2 | 1993 | 1621 | 0.030 |
Why?
| Immunity, Mucosal | 1 | 1997 | 84 | 0.030 |
Why?
| Molecular Conformation | 2 | 2009 | 135 | 0.030 |
Why?
| Sequence Homology | 1 | 1995 | 39 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 3 | 2003 | 511 | 0.030 |
Why?
| Nitrophenols | 4 | 2004 | 32 | 0.030 |
Why?
| Liposomes | 2 | 2005 | 146 | 0.030 |
Why?
| Molecular Structure | 2 | 2003 | 434 | 0.030 |
Why?
| Immunoglobulins | 2 | 1987 | 143 | 0.030 |
Why?
| Epitope Mapping | 2 | 2011 | 51 | 0.030 |
Why?
| Databases, Factual | 1 | 2000 | 1125 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 235 | 0.030 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| Receptors, Nicotinic | 1 | 2017 | 274 | 0.030 |
Why?
| Immunoglobulin E | 2 | 1997 | 314 | 0.030 |
Why?
| Histocompatibility Testing | 1 | 2015 | 116 | 0.030 |
Why?
| Insecta | 2 | 2006 | 64 | 0.030 |
Why?
| gamma-Globulins | 4 | 1983 | 18 | 0.030 |
Why?
| Antilymphocyte Serum | 8 | 1981 | 60 | 0.030 |
Why?
| Protein Transport | 2 | 2008 | 395 | 0.030 |
Why?
| V(D)J Recombination | 1 | 2014 | 3 | 0.030 |
Why?
| Peptide Biosynthesis | 1 | 1994 | 13 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 347 | 0.030 |
Why?
| Cysteine | 2 | 2010 | 171 | 0.030 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 34 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 144 | 0.030 |
Why?
| United States | 3 | 2015 | 12183 | 0.030 |
Why?
| Cell Adhesion | 3 | 1999 | 432 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 129 | 0.030 |
Why?
| Horses | 4 | 1981 | 96 | 0.030 |
Why?
| CD4-CD8 Ratio | 1 | 1993 | 19 | 0.030 |
Why?
| Transplantation, Homologous | 1 | 2015 | 377 | 0.030 |
Why?
| Transferrin | 1 | 1993 | 39 | 0.030 |
Why?
| Disulfides | 2 | 1984 | 90 | 0.030 |
Why?
| Transplantation Immunology | 1 | 1993 | 30 | 0.030 |
Why?
| Cell Transplantation | 1 | 1993 | 36 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 345 | 0.030 |
Why?
| Multigene Family | 2 | 1991 | 190 | 0.030 |
Why?
| Sodium | 1 | 2014 | 183 | 0.030 |
Why?
| Trypsin | 4 | 2006 | 66 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 520 | 0.030 |
Why?
| Hydrogen Bonding | 2 | 2008 | 143 | 0.030 |
Why?
| Viral Envelope Proteins | 1 | 1994 | 73 | 0.030 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 170 | 0.030 |
Why?
| Endopeptidase K | 1 | 2013 | 14 | 0.030 |
Why?
| Growth Substances | 2 | 1983 | 138 | 0.030 |
Why?
| Blotting, Southern | 1 | 1993 | 68 | 0.030 |
Why?
| Interleukin-2 Receptor beta Subunit | 1 | 2013 | 19 | 0.030 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.030 |
Why?
| HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 24 | 0.030 |
Why?
| Hepatocytes | 1 | 2014 | 195 | 0.030 |
Why?
| Vomiting | 1 | 1993 | 123 | 0.030 |
Why?
| DNA Methylation | 1 | 1996 | 495 | 0.030 |
Why?
| Intestinal Mucosa | 1 | 1997 | 532 | 0.030 |
Why?
| Mice, Inbred MRL lpr | 1 | 2012 | 37 | 0.030 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 100 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1992 | 94 | 0.020 |
Why?
| Perissodactyla | 4 | 1981 | 12 | 0.020 |
Why?
| Disease | 1 | 1993 | 85 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2012 | 228 | 0.020 |
Why?
| Immunoassay | 2 | 1989 | 95 | 0.020 |
Why?
| Immunotherapy, Adoptive | 1 | 1993 | 184 | 0.020 |
Why?
| Ionomycin | 1 | 1991 | 24 | 0.020 |
Why?
| Cellular Senescence | 1 | 1993 | 152 | 0.020 |
Why?
| Oligonucleotides, Antisense | 1 | 1992 | 100 | 0.020 |
Why?
| Tumor Burden | 1 | 2012 | 259 | 0.020 |
Why?
| Genotype | 1 | 1996 | 1760 | 0.020 |
Why?
| DNA, Recombinant | 3 | 2005 | 41 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1991 | 153 | 0.020 |
Why?
| Pregnancy | 2 | 2014 | 5518 | 0.020 |
Why?
| Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| Analysis of Variance | 1 | 2014 | 1226 | 0.020 |
Why?
| Mice, Inbred NZB | 2 | 2007 | 15 | 0.020 |
Why?
| Glycosylation | 4 | 1994 | 130 | 0.020 |
Why?
| Blotting, Northern | 1 | 1991 | 193 | 0.020 |
Why?
| Lysine | 1 | 2012 | 242 | 0.020 |
Why?
| Mutant Chimeric Proteins | 1 | 2010 | 3 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1992 | 311 | 0.020 |
Why?
| Smoking | 1 | 2017 | 1383 | 0.020 |
Why?
| Kidney Diseases | 1 | 2014 | 350 | 0.020 |
Why?
| RNA Splicing | 1 | 1991 | 245 | 0.020 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.020 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 5 | 0.020 |
Why?
| Depression, Chemical | 1 | 1990 | 22 | 0.020 |
Why?
| Milk | 1 | 1991 | 124 | 0.020 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 54 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 49 | 0.020 |
Why?
| Epoprostenol | 1 | 1991 | 133 | 0.020 |
Why?
| Amidohydrolases | 1 | 1990 | 28 | 0.020 |
Why?
| Restriction Mapping | 3 | 1998 | 77 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2013 | 444 | 0.020 |
Why?
| Multiprotein Complexes | 1 | 2011 | 140 | 0.020 |
Why?
| Histidine | 2 | 2003 | 57 | 0.020 |
Why?
| Precipitin Tests | 2 | 1991 | 88 | 0.020 |
Why?
| Gestational Age | 1 | 1992 | 760 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 463 | 0.020 |
Why?
| Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Eosinophils | 2 | 2004 | 278 | 0.020 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 13 | 0.020 |
Why?
| Homozygote | 1 | 1989 | 187 | 0.020 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 34 | 0.020 |
Why?
| Shock, Septic | 1 | 1990 | 186 | 0.020 |
Why?
| Animals, Newborn | 2 | 1988 | 778 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 42 | 0.020 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 26 | 0.020 |
Why?
| Heterozygote | 1 | 1989 | 251 | 0.020 |
Why?
| Glutamic Acid | 1 | 2010 | 211 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 137 | 0.020 |
Why?
| Immune Sera | 2 | 2005 | 79 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2008 | 78 | 0.020 |
Why?
| Microspheres | 1 | 1988 | 123 | 0.020 |
Why?
| Immunoblotting | 1 | 2008 | 283 | 0.020 |
Why?
| Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| Leukocyte Count | 1 | 1988 | 293 | 0.020 |
Why?
| Epithelial Cells | 1 | 1993 | 951 | 0.020 |
Why?
| Mice, Congenic | 1 | 2007 | 21 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 115 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2008 | 97 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2007 | 57 | 0.020 |
Why?
| Biological Transport | 2 | 1999 | 373 | 0.020 |
Why?
| Weight Loss | 1 | 1992 | 642 | 0.020 |
Why?
| Cytoplasm | 2 | 2004 | 255 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 47 | 0.020 |
Why?
| Liver | 2 | 1992 | 1637 | 0.020 |
Why?
| Immunoglobulin gamma-Chains | 1 | 1986 | 3 | 0.020 |
Why?
| Antibodies, Antinuclear | 1 | 2006 | 58 | 0.020 |
Why?
| Proteinuria | 1 | 2006 | 77 | 0.020 |
Why?
| Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| Proteins | 2 | 1982 | 908 | 0.020 |
Why?
| Glass | 1 | 1986 | 42 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2006 | 100 | 0.020 |
Why?
| Liver Transplantation | 1 | 1992 | 707 | 0.020 |
Why?
| Prevalence | 1 | 2012 | 2251 | 0.020 |
Why?
| Body Weight | 1 | 1990 | 869 | 0.020 |
Why?
| Mast-Cell Sarcoma | 1 | 1985 | 4 | 0.020 |
Why?
| Transformation, Genetic | 1 | 1985 | 15 | 0.020 |
Why?
| Cricetinae | 3 | 1994 | 253 | 0.020 |
Why?
| Stereoisomerism | 1 | 2005 | 91 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 2005 | 134 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2004 | 17 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 362 | 0.010 |
Why?
| Rosette Formation | 2 | 1980 | 14 | 0.010 |
Why?
| Isoelectric Point | 1 | 1984 | 22 | 0.010 |
Why?
| Genetic Markers | 1 | 1985 | 320 | 0.010 |
Why?
| Gene Library | 1 | 2004 | 114 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1983 | 33 | 0.010 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 174 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 140 | 0.010 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 154 | 0.010 |
Why?
| Receptors, CCR5 | 1 | 2003 | 54 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.010 |
Why?
| Birds | 1 | 1983 | 76 | 0.010 |
Why?
| Karyotyping | 1 | 1983 | 102 | 0.010 |
Why?
| Phosphates | 1 | 2004 | 159 | 0.010 |
Why?
| Rabbits | 3 | 1984 | 733 | 0.010 |
Why?
| Phosphoproteins | 1 | 2005 | 298 | 0.010 |
Why?
| Oxidopamine | 1 | 2002 | 12 | 0.010 |
Why?
| Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| Sympatholytics | 1 | 2002 | 13 | 0.010 |
Why?
| DNA, Viral | 1 | 2004 | 350 | 0.010 |
Why?
| Transplantation, Heterotopic | 1 | 2002 | 16 | 0.010 |
Why?
| Interleukin-5 | 1 | 1982 | 30 | 0.010 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2002 | 68 | 0.010 |
Why?
| X Chromosome | 1 | 1981 | 47 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 398 | 0.010 |
Why?
| DNA Restriction Enzymes | 3 | 1986 | 54 | 0.010 |
Why?
| Immunoglobulin Constant Regions | 3 | 1986 | 6 | 0.010 |
Why?
| Methamphetamine | 1 | 2002 | 51 | 0.010 |
Why?
| Thymectomy | 3 | 1975 | 15 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 723 | 0.010 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 551 | 0.010 |
Why?
| Genes, Reporter | 1 | 2001 | 257 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 268 | 0.010 |
Why?
| Chromatography, Gel | 2 | 1983 | 122 | 0.010 |
Why?
| Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| Biopolymers | 1 | 2000 | 26 | 0.010 |
Why?
| Corpus Striatum | 1 | 2002 | 126 | 0.010 |
Why?
| Lyme Disease | 1 | 2000 | 32 | 0.010 |
Why?
| HLA-DRB1 Chains | 1 | 2000 | 98 | 0.010 |
Why?
| Bacterial Vaccines | 1 | 2000 | 61 | 0.010 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| Genes, Dominant | 1 | 1999 | 94 | 0.010 |
Why?
| Staining and Labeling | 1 | 1980 | 134 | 0.010 |
Why?
| Dopamine | 1 | 2002 | 236 | 0.010 |
Why?
| Androstadienes | 1 | 1999 | 97 | 0.010 |
Why?
| Computer Simulation | 1 | 2003 | 873 | 0.010 |
Why?
| Immunization, Secondary | 1 | 1999 | 82 | 0.010 |
Why?
| Public Policy | 1 | 1999 | 61 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 146 | 0.010 |
Why?
| Half-Life | 2 | 1977 | 141 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 164 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 260 | 0.010 |
Why?
| Cartilage | 1 | 2000 | 182 | 0.010 |
Why?
| Asparagine | 1 | 1998 | 29 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 1999 | 278 | 0.010 |
Why?
| Polysaccharides, Bacterial | 2 | 1975 | 66 | 0.010 |
Why?
| Histocompatibility | 1 | 1977 | 26 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1999 | 396 | 0.010 |
Why?
| Codon | 1 | 1998 | 86 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 329 | 0.010 |
Why?
| Collagen | 1 | 2000 | 415 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 1629 | 0.010 |
Why?
| Warfarin | 1 | 1978 | 135 | 0.010 |
Why?
| Dimerization | 1 | 1997 | 176 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2002 | 2218 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 750 | 0.010 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 84 | 0.010 |
Why?
| Research | 1 | 1999 | 394 | 0.010 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1996 | 61 | 0.010 |
Why?
| Radiation Effects | 1 | 1975 | 4 | 0.010 |
Why?
| Absorption | 1 | 1975 | 52 | 0.010 |
Why?
| Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| Surface Properties | 1 | 1976 | 387 | 0.010 |
Why?
| Trachea | 1 | 1997 | 224 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1994 | 71 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 315 | 0.010 |
Why?
| Neurons | 1 | 2002 | 1280 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 71 | 0.010 |
Why?
| Golgi Apparatus | 1 | 1994 | 89 | 0.010 |
Why?
| Umbilical Cord | 1 | 1994 | 80 | 0.010 |
Why?
| Immunologic Techniques | 2 | 1983 | 39 | 0.010 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1983 | 53 | 0.010 |
Why?
| Macaca mulatta | 1 | 1993 | 131 | 0.010 |
Why?
| Pedigree | 1 | 1994 | 460 | 0.010 |
Why?
| Zinc | 1 | 1995 | 260 | 0.010 |
Why?
| Genetic Variation | 2 | 1990 | 870 | 0.010 |
Why?
| Drug Synergism | 2 | 1983 | 316 | 0.010 |
Why?
| Microsomes | 1 | 1992 | 24 | 0.010 |
Why?
| Models, Structural | 1 | 1991 | 37 | 0.010 |
Why?
| Methionine | 1 | 1992 | 144 | 0.010 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| Calcimycin | 1 | 1991 | 47 | 0.010 |
Why?
| Carbohydrates | 1 | 1991 | 55 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 847 | 0.010 |
Why?
| Arthritis | 1 | 1991 | 109 | 0.010 |
Why?
| Genes, MHC Class I | 1 | 1990 | 32 | 0.010 |
Why?
| Cricetulus | 1 | 1989 | 97 | 0.010 |
Why?
| Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.010 |
Why?
| Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.010 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 16 | 0.000 |
Why?
| Reference Values | 1 | 1990 | 743 | 0.000 |
Why?
| Phosphorylcholine | 1 | 1988 | 17 | 0.000 |
Why?
| Extracellular Space | 1 | 1989 | 116 | 0.000 |
Why?
| Cross-Linking Reagents | 1 | 1989 | 181 | 0.000 |
Why?
| Introns | 1 | 1988 | 227 | 0.000 |
Why?
| Bacteriophage lambda | 1 | 1988 | 81 | 0.000 |
Why?
| Mannose | 1 | 1987 | 21 | 0.000 |
Why?
| Exons | 1 | 1988 | 302 | 0.000 |
Why?
| Hexosaminidases | 1 | 1987 | 17 | 0.000 |
Why?
| Oligosaccharides | 1 | 1987 | 46 | 0.000 |
Why?
| Enhancer Elements, Genetic | 1 | 1988 | 151 | 0.000 |
Why?
| Pepsin A | 1 | 1986 | 18 | 0.000 |
Why?
| Hypersensitivity, Delayed | 2 | 1978 | 27 | 0.000 |
Why?
| Vinblastine | 2 | 1976 | 63 | 0.000 |
Why?
| Staphylococcal Infections | 1 | 1990 | 340 | 0.000 |
Why?
| Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 192 | 0.000 |
Why?
| Genetic Code | 1 | 1985 | 20 | 0.000 |
Why?
| Immunoglobulin Light Chains | 1 | 1984 | 35 | 0.000 |
Why?
| Protein Denaturation | 1 | 1984 | 68 | 0.000 |
Why?
| Bacteria | 1 | 1991 | 725 | 0.000 |
Why?
| Membranes, Artificial | 1 | 1984 | 65 | 0.000 |
Why?
| Albumins | 1 | 1984 | 89 | 0.000 |
Why?
| Thymus Neoplasms | 1 | 1984 | 21 | 0.000 |
Why?
| Longitudinal Studies | 1 | 1990 | 2387 | 0.000 |
Why?
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.000 |
Why?
| Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| Cell-Free System | 1 | 1983 | 47 | 0.000 |
Why?
| Glutaral | 1 | 1983 | 14 | 0.000 |
Why?
| Receptors, Antigen | 1 | 1983 | 10 | 0.000 |
Why?
| Cell Nucleus | 1 | 1985 | 554 | 0.000 |
Why?
| Fetal Blood | 1 | 1983 | 270 | 0.000 |
Why?
| Pulmonary Alveoli | 1 | 1983 | 373 | 0.000 |
Why?
| Polymers | 1 | 1983 | 448 | 0.000 |
Why?
| Isoantigens | 1 | 1977 | 17 | 0.000 |
Why?
| Child | 1 | 1994 | 18414 | 0.000 |
Why?
| Skin Tests | 1 | 1975 | 116 | 0.000 |
Why?
| Immunoglobulin M | 1 | 1975 | 246 | 0.000 |
Why?
|
|
Marrack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|